Join us in Philadelphia from Sept. 25-27th for our "Together We Will" Weekend: - Register today!

Efficacy of Nirogacestat in Patients with Desmoid Tumors and Poor Prognostic Factors: Patient-Reported Outcomes, Progression-Free Survival, and Objective Response Rate in the Phase 3 DeFi Trial

November 21, 2024 by

Stay Up to Date as We Uncover More About Desmoid Tumors